(40) failed to find association between ACPA fine-specificity profiles in early rheumatoid arthritis patients and clinical features at baseline or with disease progression, however, the citrullinated peptides used in our study were not analyzed, neither rheumatoid nodules. Here, PRTN3 is linked to rheumatoid arthritis.